Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Multi-unit dwellings contribute to children's exposure to tobacco smoke

Children living in apartments are exposed to secondhand smoke even when no one smokes inside their own unit. This study, released online today by the journal Pediatrics, strongly suggests that housing type contributes to children's exposure to tobacco smoke, despite the best intentions of parents.

13 Dec 2010

Tomophase receives FDA 510(k) clearance to market Optical Coherence Tomography Imaging System

Tomophase Corporation, developer of the non-invasive Optical Coherence Tomography Imaging System (OCTIS™) and other devices, announced today that it has received FDA 510(k) clearance to market OCTIS.

10 Dec 2010

Official guidelines for diagnosis, treatment and management of food allergies released

A collaborative, government-led effort to guide and standardize diagnosis, treatment and management of food allergies has resulted in the release of an official set of recommendations for physicians.

10 Dec 2010

COPD becomes third leading cause of death in the U.S.

The Centers for Disease Control (CDC) and Prevention's National Center for Health Statistics (NCHS) released a report today, "Deaths: Preliminary Data for 2008," confirming that Chronic Obstructive Pulmonary Disease (COPD) became the third leading cause of death in the U.S. for 2008.

10 Dec 2010

Study to develop ways to track individual's exposure to traffic pollution

Researchers at King's College London are developing ways of working out a person's individual exposure to traffic pollution when travelling to, from, and around London.

9 Dec 2010

School-based intervention program helps students with asthma better manage symptoms

A school-based intervention program helped New York City high school students with moderate to severe asthma better manage their symptoms, dramatically reducing the need for urgent care, including hospitalizations and emergency room visits, according to a study published online in the American Journal of Respiratory and Critical Care Medicine.

9 Dec 2010

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.

9 Dec 2010

New NIH guidelines support broader use of blood tests to diagnose food allergy

New guidelines on diagnosis and management of food allergy issued by the National Institute of Allergy and Infectious Diseases a part of NIH, supports a broader use of blood test to improve current clinical practice. Phadia's ImmunoCAP is recognized for its superior predictive values compared to other systems. It provides precise, quantitative and standardized results and help doctors make an accurate diagnosis.

8 Dec 2010

School-based ASMA program helps adolescents improve asthma management, quality of life

A school-based intervention program designed for adolescents with asthma significantly improves asthma management and quality of life for the students who participate, and reduces asthma morbidity, according to researchers in New York City, who studied the effect of the program aimed at urban youth and their medical providers.

8 Dec 2010

Secondhand smoke in the home may cause ear infections in children: Study

Family members who smoke are more apt to feel it is OK to smoke indoors as their children get older. But in households with secondhand smoke, children between 12 and 17 are 1.67 times more prone to have recurrent ear infections compared to adolescents who live in a smoke-free environment, a large new study reveals.

7 Dec 2010

New study reveals that sick teens are more isolated than other kids

A new study reveals that sick teens are more isolated than other kids, but they do not necessarily realize it and often think their friendships are stronger than they actually are.

7 Dec 2010

Cyclacel reports preclinical data of CYC065 for treatment of cancer, other serious diseases

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.

6 Dec 2010

ACAAI allergist experts available to comment on new food allergy guidelines

Food allergy experts from the American College of Allergy, Asthma and Immunology are available to comment as the National Institute of Allergy and Infectious Diseases releases the Guidelines for the Diagnosis and Management of Food Allergy on December 6. The ACAAI was one of more than 30 professional organizations, federal agencies and lay organizations who collaborated on the development of these recommendations.

6 Dec 2010

Ligand Pharmaceuticals reports preclinical study data on erythropoietin receptor agonists

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced data from a preclinical study on the erythropoietin (EPO) receptor agonist LG5640 at the upcoming 52nd American Society of Hematology (ASH) Annual Meeting being held in Orlando, Florida at the Orange County Convention Center, December 4 - 7, 2010.

6 Dec 2010

Merck to present multiple clinical studies of dinaciclib at ASH Annual Meeting

Ligand Pharmaceuticals Incorporated today announced that multiple clinical studies of dinaciclib (SCH 727965) will be presented by Merck at the upcoming 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida at the Orange County Convention Center, December 4-7, 2010.

4 Dec 2010

3M announces availability of TLR compounds for nonvaccine use in pharmaceutical industry

3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.

3 Dec 2010

Online program enhances patient's ability to self manage chronic health conditions: Study

A study conducted by HealthMedia, Inc. and Highmark Inc., published in the November/December edition of the American Journal of Health Promotion, proves that an online program offers a return on investment and enhances a patient's ability to self manage chronic health conditions.

2 Dec 2010

NHS to develop new treatment options for patients with lung disease

Scientists and clinicians in Nottingham are to work more closely with industry to develop new ways of diagnosing and treating lung disease.

2 Dec 2010

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).

2 Dec 2010

New study evaluates use and safety of complementary medicine for children's asthma

Approximately 13 percent of parents turn to alternative therapies to treat their children's asthma, according to a new study from the Universit- de Montr-al. The findings, published recently in the Canadian Respiratory Journal, suggest that this trend is associated with a two-fold higher rate of poor asthma control in children.

1 Dec 2010

Asthma News and Research

Further Reading

Multi-unit dwellings contribute to children's exposure to tobacco smoke

Tomophase receives FDA 510(k) clearance to market Optical Coherence Tomography Imaging System

Official guidelines for diagnosis, treatment and management of food allergies released

COPD becomes third leading cause of death in the U.S.

Study to develop ways to track individual's exposure to traffic pollution

School-based intervention program helps students with asthma better manage symptoms

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

New NIH guidelines support broader use of blood tests to diagnose food allergy

School-based ASMA program helps adolescents improve asthma management, quality of life

Secondhand smoke in the home may cause ear infections in children: Study

New study reveals that sick teens are more isolated than other kids

Cyclacel reports preclinical data of CYC065 for treatment of cancer, other serious diseases

ACAAI allergist experts available to comment on new food allergy guidelines

Ligand Pharmaceuticals reports preclinical study data on erythropoietin receptor agonists

Merck to present multiple clinical studies of dinaciclib at ASH Annual Meeting

3M announces availability of TLR compounds for nonvaccine use in pharmaceutical industry

Online program enhances patient's ability to self manage chronic health conditions: Study

NHS to develop new treatment options for patients with lung disease

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

New study evaluates use and safety of complementary medicine for children's asthma

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News